The Courtyard by Marriott Philadelphia South at the Navy Yard completes expansion

Excited to be a part of the exciting growth of the Philadelphia Navy Yard, the Courtyard Philadelphia South announces the completed expansion with a new neighboring building providing an additional 42 guest rooms. The addition will accommodate the visitor demand of the Navy Yard and Philadelphia’s major sports venues. Already the recipient of the TripAdvisor Certificate of Excellence, this modern hotel prides itself on not only its close proximity to much of the area’s most popular attractions, but for its unparalleled service, amenities, and value to its guests. Read more

3 Crescent Drive

Jefferson Announces Plans for Expanded Services at the Navy Yard

Jefferson Health will offer expanded services at the Navy Yard, having signed a multi-year lease agreement with Liberty Property/Synterra, a joint venture of Liberty Property Trust and Synterra Partners, for additional space to open a 70,000-plus square-foot facility at 3 Crescent Drive by early to mid-2018. Read more

James Noble, CEO of Adaptimmune (center with scissors) with (left to right) Craig Tucker, Vice President, Policy & Public Affairs at Life Sciences Pennsylvania; John Gattuso, Senior Vice President, Regional Director, Liberty Property Trust; Councilman Kenyetta Johnson, District 2 – Philadelphia City Council; Mayor Jim Kenney – Mayor of the City of Philadelphia; State Senator Larry Farnese, 1st Senatorial District; John Grady, President, PIDC; Secretary Dennis Davin – Secretary, Department of Community and Economic Development

Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia

Adaptimmune Therapeutics plc. (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced it will host a ribbon cutting ceremony this morning at 10:30am at the Navy Yard in Philadelphia to celebrate the opening of its newly constructed U.S. headquarters and base for clinical and manufacturing operations. Developed by Liberty Property Trust (NYSE: LPT) and Synterra Partners, and under advisement of CBRE’s Life Science Advisory and Project Management Group, Adaptimmune’s 47,400 square foot facility, located at 351 Rouse Boulevard will include a state-of-the-art cGMP manufacturing facility designed to support the Company’s clinical development objectives and the initial commercialization of novel engineered immunotherapies for cancer. Adaptimmune’s Navy Yard facility currently houses 91 employees; this number is expected to grow to 120 by the end of 2017.

Read more